Rodman & Renshaw Archives - Page 7 of 44

MondayNov 03, 2008 6:38 am

ZBB Energy Corporation (AMEX: ZBB)

ZBB Energy Corporation (AMEX: ZBB), a leading innovator of energy storage systems, is focused on providing energy storage systems to utility companies, industrial and commercial organizations and renewable energy generators. The company’s aim is to develop and produce products that increase energy efficiency, minimize the impact on the environment and maximize the use of renewable energy. Founded in 1981, ZBB is headquartered in Wisconsin with offices located in Perth, Australia. For further information, visit the Company's web site at www.zbbenergy.com.

MondayNov 03, 2008 6:38 am

Generex Biotechnology Corporation (NASDAQ: GNBT)

Generex Biotechnology Corporation (NASDAQ: GNBT), a biopharmaceutical company, has a diversified product portfolio designed to deliver innovative products to treat patients with cancer. DNA/RNA-based Medicines and Small Molecules are the two major programs that anchor the Company's research platform. Ganite® (gallium nitrate injection) is the company’s leading drug in the Small Molecule program. Ganite is exclusively marketed in the U.S. to treat symptomatic patients with cancer-related hypercalcemia that is resistant to hydration. For further information, visit the Company's web site at www.genta.com.

MondayNov 03, 2008 6:37 am

YM BioSciences, Inc. (AMEX: YMI)

YM BioSciences, Inc. (AMEX: YMI), an oncology company, is focused on identifying, developing and commercializing a variety of products for patients on a global basis. The Company is advancing two late-stage products: Nimotuzumab, a humanized monoclonal antibody designed to target the epidermal growth factor receptor (EGFR); and AeroLEF®, a proprietary, inhaled-delivery composition of free and liposome-encapsulated fentanyl. Nimotuzumab has received approval in multiple countries for treating types of head and neck cancer, while AeroLEF is in development for the treatment of moderate to severe pain. For further information, visit the Company's web site at www.ymbiosciences.com.

MondayNov 03, 2008 6:37 am

Genco Resources Ltd. (TSX: GGC CN)

Genco Resources Ltd. (TSX: GGC CN), a junior silver mining company, has its core assets in a number of mining sites including the La Guitarra Mine. This mine is located within the Sierra Madre silver and gold Metallogenic Province that has historically produced some of the world's most extraordinary mines. The La Guitarra Mine produces precious metals from a classic epithermal vein system, part of a mineralized corridor that measures 15 kilometers in length and averages 4 kilometers in width. For further information, visit the Company's web site at www.gencoresources.com.

MondayNov 03, 2008 6:37 am

Xsunx, Inc. (OTC BB: XSNX)

Xsunx, Inc. (OTC BB: XSNX), a thin-film photovoltaic (“TFPV”) company, is focused on executing a phased plan to build and install 100 mega-watts (MW) of amorphous silicon (“a-Si”) thin film solar module manufacturing capacity. XsunX has designed its TFPV product to service a wide range of installation environments and deliver performance characteristics that address the needs of solar farm and utility grade applications. For further information, visit the Company's web site at www.xsunx.com.

MondayNov 03, 2008 6:36 am

XOMA, Ltd. (NASDAQ: XOMA)

XOMA, Ltd. (NASDAQ: XOMA) is focused on the discovery and development of antibodies, one of the most powerful and transformative fields of drug innovation today. By building on its pioneering proprietary pipeline, antibody discovery and development platform, and multiple revenue streams, the company is creating novel human antibody therapeutics that could revolutionize medicine and reshape people’s lives. For further information, visit the Company's web site at www.xoma.com.

MondayNov 03, 2008 6:36 am

Genaera Corporation (NASDAQ: GENR)

Genaera Corporation (NASDAQ: GENR) has their efforts focused on advancing the science and treatment of metabolic diseases. They have identified significant market opportunities with a first-in-class molecule that may revolutionize the treatment paradigm for obesity and type 2 diabetes. They currently have two products in their pipeline: MSI-1436 , the core internal asset of Genaera designed to treat obesity and has applicability in type 2 diabetes; and MEDI-528, which is under evaluation in Phase 2 clinical studies for the treatment of asthma. For further information, visit the Company's web site at www.genaera.com Generex is focused on researching, developing, and commercializing…

MondayNov 03, 2008 6:35 am

XenoPort, Inc. (NASDAQ: XNPT)

XenoPort, Inc. (NASDAQ: XNPT), a biopharmaceutical company, focuses their efforts on developing a portfolio of internally discovered product candidates that leverage the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of drugs. The company has directed their focus on developing and commercializing on potential treatments of central nervous system, or CNS, disorders. Their most advanced product candidate, XP13512 (also known as Solzira™), is in the process of being evaluated for the treatment of restless legs syndrome, or RLS, in a Phase 3 clinical program. For further information, visit the Company's web site at www.xenoport.com.

MondayNov 03, 2008 6:34 am

Gastar Exploration, Ltd. (AMEX: GST)

Gastar Exploration, Ltd. (AMEX: GST), a Houston-based independent E&P company, is focused on the exploration, development and production of natural gas and oil in the United States and Australia. The company’s drilling operations are concentrated on exploiting locations in the Deep Bossier Sands and Knowles Limestone plays in the Hilltop area of East Texas and the emerging Marcellus Shale play in Appalachia, along with coalbed methane, or "CBM" development in southeast Australia and the Rocky Mountains. For further information, visit the Company's web site at www.gastar.com.

MondayNov 03, 2008 6:34 am

Wuhan General Group, Inc. (NASDAQ: WUHN)

Wuhan General Group, Inc. (NASDAQ: WUHN) is a holding company that designs, manufactures, and distributes industrial blowers and turbines. Wuhan’s primary business operations are conducted through its operating subsidiaries Wuhan Blower Co., Ltd. (Wuhan Blower) and Wuhan Generating Equipment Co., Ltd. (Wuhan Generating Equipment). Wuhan was formerly known as the United Nations Film Corporation and has been a major player in the power generation field since its inception. For further information, visit the company website at: www.wuhangeneral.com.

Site Search

Company Search

Tag: Rodman & Renshaw

ZBB Energy Corporation (AMEX: ZBB)

Generex Biotechnology Corporation (NASDAQ: GNBT)

YM BioSciences, Inc. (AMEX: YMI)

Genco Resources Ltd. (TSX: GGC CN)

Xsunx, Inc. (OTC BB: XSNX)

XOMA, Ltd. (NASDAQ: XOMA)

Genaera Corporation (NASDAQ: GENR)

XenoPort, Inc. (NASDAQ: XNPT)

Gastar Exploration, Ltd. (AMEX: GST)

Wuhan General Group, Inc. (NASDAQ: WUHN)

Market Basics

Newsletter Publishers

Public Companies